This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

4 Jun 2012

Report Highlights Importance of Communication for Pharma-biotech Deals

Open and frequent communication is vitally important for the success of partnerships between pharmaceutical and biotech companies.

Drug development and commercialisation partnerships between pharmaceutical and biotech companies rely on strong communication, a report has found.


Cutting Edge Information's latest research looked at the most common types of conflict that threaten pharma-biotech alliances.


The research and consulting firm found that the most common problems include unrealistic goals, clashing corporate cultures and disagreements over the partners' responsibilities.


Communication breakdown featured highly on the list of conflicts and Cutting Edge Information pointed out that many of the most common issues can be overcome with open communication.


Related News